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CASE REPORT
A distinct variant of papillary thyroid 
carcinoma indicating familial adenomatous 
polyposis (FAP): a case report and brief review
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Abstract 
Background: Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited intestinal polyposis syn-
drome with an incidence of about 1/8300 births and accounts for about 1 % of all colorectal cancers. It has a spec-
trum of extra-intestinal manifestations including thyroid carcinoma which occur in 1–2 % of affected. The cribriform 
morular variant (CMV) is a rare but distinct histological subtype of papillary thyroid carcinoma (PTC) associated with 
FAP. Most of the reported cases describe the above entity in the background of well-established FAP. We report a case 
where both entities presenting simultaneously in a previously undiagnosed patient with FAP without a family history 
of polyposis.
Case presentation: A 24 year old Asian female presented to the surgical clinic with a goitre of eight months duration 
and recent onset of altered bowel habits with features of anaemia. She was previously healthy and there was no fam-
ily history of adenomatous polyposis, colorectal carcinoma or thyroid neoplasms. Colonoscopy revealed large bowel 
polyposis and fine needle aspiration of thyroid revealed a smear suspicious for malignancy. She underwent total 
thyroidectomy which revealed CMV PTC. Histology was characterized by a prominent cribriform pattern of growth 
with interspersed cell clusters arranged as morules along with papillary structures which are the key features of this 
subtype.
Conclusion: Diagnosis of CMV warrants ruling out of underlying FAP, irrespective of family history or gastrointestinal 
symptoms.
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Background
Familial adenomatous polyposis (FAP) is an inherited 
autosomal dominant syndrome which is characterized 
by innumerable colorectal polyps that have an intrinsic 
tendency to progress to adenocarcinoma. Extra intesti-
nal manifestations including papillary thyroid carcinoma 
(PTC) are well described in FAP. The cribriform moru-
lar variant (CMV), a distinct and a rare sub type of PTC 
associated with FAP, has been reported in the literature 
previously, but in limited numbers. However most of 
the reported cases describe the above entity in the back-
ground of well-established FAP. We report a case where 
both entities presenting simultaneously in a previously 
undiagnosed patient with FAP without a family history of 
polyposis.
Case report
A 24  year old Asian female presented to the surgical 
clinic with a goitre of eight months duration and recent 
onset of altered bowel habits (i.e., increased stool fre-
quency) with features of anaemia. She was otherwise well 
and there was no family history of adenomatous polypo-
sis, colorectal carcinoma or thyroid neoplasms. Physical 
examination revealed a multi nodular goitre. Ultrasoni-
cally both lobes of the thyroid gland were enlarged with 
multiple hyper-echoic nodules with central irregularity 
denoting necrosis. Fine needle aspiration cytology was 
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compatible with a smear suspicious of papillary thyroid 
malignancy. The patient was biochemically euthyroid and 
antithyroid antibody status was negative.
Colonoscopy revealed multiple polyps (more than 100) 
of varying sizes from the caecum extending to the rec-
tum. Histology showed adenomatous polyps with low 
grade dysplasia rendering the diagnosis of FAP.
She underwent a total thyroidectomy with level VI 
lymph node dissection and the recovery was unevent-
ful. Macroscopy revealed multiple circumscribed whit-
ish tumours of varying sizes in both thyroid lobes (Fig. 1). 
There were 14 separate tumours in total, the largest 
measuring 18 × 17 × 14 mm in size. Some of the lesions 
contained areas of haemorrhages and cystic changes.
Microscopically, all the tumours showed predominant 
features of encapsulated PTC. However, unlike in the 
usual PTC, a variety of architectural growth patterns 
including cribriform, solid and trabecular with morule 
formation were noted along with the papillary structures 
(Fig. 2). Constituent cells were cuboidal to columnar with 
amphophilic cytoplasm. Spindle shaped cells were noted 
in morular structures. Capsular invasion was seen in one 
tumour but there was no evidence of vascular invasion. 
The lymph nodes were free of metastases.
The patient was started on high dose thyroxine replace-
ment and referred for radio iodine treatment. Disease 
involvement of the small bowel was excluded with cap-
sule endoscopy and restorative proctocolectomy is being 
planned for the colonic polyposis. Colonoscopy screen-
ing of her two brothers and parents was found to be neg-
ative for FAP.
Discussion and conclusion
FAP is an autosomal dominantly inherited intestinal 
polyposis syndrome, which occurs due to a germ line 
mutation of the adenomatous polyposis coli (APC) gene 
located on chromosome 5q21. It is characterized by the 
development of multiple adenomatous polyps through-
out the colon which invariably leads to colorectal car-
cinoma. Although FAP is inherited in an autosomal 
dominant mode, it is also reported to occur in 25–30 % 
as “De Novo” [1]. Further it exhibits variable pen-
etrance with marked inter and intra familial variations. 
Extra intestinal manifestations in FAP includes malig-
nancies such as thyroid and pancreatic cancer, hepato-
blastomas, central nervous system tumours (especially 
medulloblastomas) and various benign tumours such 
as adrenal adenomas, osteomas, desmoid tumours and 
dental abnormalities. The relationship between FAP and 
thyroid carcinoma was first suggested in 1968 [2]. The 
CMV of PTC was first recognized by Harach et  al. [3] 
as a peculiar form of thyroid carcinoma developing in 
patients with FAP, and the term CMV was proposed by 
Cameselle-Teijeiro and Chan in 1999 [6]. It is character-
ized by female predominance (female/male ratio—17:1) 
and the mean age of presentation is 30  years. In over 
90 % of patients with FAP and PTC, histologic features 
are compatible with CMV and most exhibit multifocal 
development [4, 5]. There are reported cases of sporadic 
CMV of PTC in the absence of FAP, which are often soli-
tary [6, 7].
The CMV has a very unusual histology, character-
ized by a prominent cribriform pattern of growth with 
interspersed cell clusters arranged in squamoid islands 
(morules) [6]. The cribriform areas are composed of 
anastomosing bars and arches of cells without interven-
ing stroma with the follicular spaces devoid of colloid 
(Fig.  2a). They are typically formed by cuboidal or tall 
cells [8].
Morules consists of solid areas where whorls of cell 
clusters are arranged as nests (Fig.  2c). They are mainly 
composed of spindle and oval shaped tumour cells. 
Nuclei of these cells exhibit a characteristic pale staining 
(“peculiar nuclear clearing”) which differ them from both 
optically clear nuclei (Orphan Annie appearance) and 
intranuclear pseudo-inclusions that are more typically 
seen in PTC [8].
Molecular genetic studies are carried out in suspected 
FAP using PCR analysis in both the tumour tissue and the 
patient’s white blood cells. While it detects the presence 
of APC gene mutation it also confirms whether there is 
a germline mutation (observed in FAP associated CMV 
PTC) or a somatic mutation (observed in sporadic cases). 
However an alternative pathway with aberrant nuclear 
accumulation of beta-catenin which results from muta-
tion of beta-catenin gene (CTNNB1), substituting the 
APC mutation has also been observed in some cases of 
CMV PTC [9]. Although our patient refused to undergo 
genetic analysis, presence of colonic polyposis and the 
Fig. 1 Macroscopic appearance of the tumour displaying multifocal-
ity
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younger presenting age strongly suggested the possibility 
of FAP associated CMV of PTC.
Immunohistochemically, the hallmark feature of these 
tumours which differentiates them from classical PTC 
is the intra-cytoplasmic and intra-nuclear positivity for 
beta-catenin. In classical PTC beta-catenin activity is 
only limited to the cell membranes, which highlights 
the role of aberrant cellular and nuclear accumulation 
of beta-catenin resulting from mutant APC or CTNNB1 
gene, in triggering this peculiar variant [8].
Distant metastasis is rarely observed in CMV of PTC 
and the standard treatment consists of total thyroidec-
tomy followed by radioiodine therapy [6, 10]. Good long 
term prognosis with a five year survival rate of over 90 % 
and 20  year survival rate of 77  % has been observed in 
FAP associated CMV PTC [6, 10], which is comparable to 
classical PTC. This highlights the significance of appre-
ciation of histological features and accurate diagnosis 
of this variant since it can be mistaken for PTC variants 
with comparatively poorer prognosis such as tall cell var-
iant, columnar cell variant and poorly differentiated thy-
roid cancer [7, 11].
In conclusion, this is a rare but an important variant 
of thyroid carcinoma where both the clinicians and the 
pathologists should be familiar with. The diagnosis of 
CMV especially when it is multifocal, warrants ruling out 
of underlying FAP even in the absence of previously well-
established diagnosis of the intestinal polyposis.
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Fig. 2 Microscopic appearance of Cribriform morular variant of papillary thyroid carcinoma, showing all under mentioned features in the same 
tumour. a Cribriform growth pattern. b Papillary growth pattern. c Characteristic whorls of cell nests forming morules. d Cytological details—
rounded cells with clear nuclei
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